Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP541416.RAHnQ1N287NQbX1doUo0dcO5gEIU3ye4CdkfTfwp2dzlM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP541416.RAHnQ1N287NQbX1doUo0dcO5gEIU3ye4CdkfTfwp2dzlM130_assertion type Assertion NP541416.RAHnQ1N287NQbX1doUo0dcO5gEIU3ye4CdkfTfwp2dzlM130_head.
- NP541416.RAHnQ1N287NQbX1doUo0dcO5gEIU3ye4CdkfTfwp2dzlM130_assertion description "[In subjects receiving dolasetron, carriers of the duplication of the CYP2D6 allele predicting ultrarapid metabolizer status had more frequent vomiting episodes (P < 0.05) than patients in the granisetron group.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP541416.RAHnQ1N287NQbX1doUo0dcO5gEIU3ye4CdkfTfwp2dzlM130_provenance.
- NP541416.RAHnQ1N287NQbX1doUo0dcO5gEIU3ye4CdkfTfwp2dzlM130_assertion evidence source_evidence_literature NP541416.RAHnQ1N287NQbX1doUo0dcO5gEIU3ye4CdkfTfwp2dzlM130_provenance.
- NP541416.RAHnQ1N287NQbX1doUo0dcO5gEIU3ye4CdkfTfwp2dzlM130_assertion SIO_000772 16551910 NP541416.RAHnQ1N287NQbX1doUo0dcO5gEIU3ye4CdkfTfwp2dzlM130_provenance.
- NP541416.RAHnQ1N287NQbX1doUo0dcO5gEIU3ye4CdkfTfwp2dzlM130_assertion wasDerivedFrom befree-2016 NP541416.RAHnQ1N287NQbX1doUo0dcO5gEIU3ye4CdkfTfwp2dzlM130_provenance.
- NP541416.RAHnQ1N287NQbX1doUo0dcO5gEIU3ye4CdkfTfwp2dzlM130_assertion wasGeneratedBy ECO_0000203 NP541416.RAHnQ1N287NQbX1doUo0dcO5gEIU3ye4CdkfTfwp2dzlM130_provenance.